welcome to oneFAPvoice- a positively charged Familial Adenomatous Polyposis community.
- join today!
Coxib-inhibition of Duodenal Polyp Growth in FAP
study id #: NCT00844727
condition: Duodenal Polyposis
Preliminary data indicate a protective effect on the development of duodenal polyps by coxib treatment. The hypothesis of the present study is that normal therapy doses of rofecoxib for 1 year would stop or reverse the development of premalignant adenomatous lesions in the duodenal mucosa of FAP patients.
start date: September 2003
estimated completion: April 2004
last updated: July 6, 2011
phase of development: Phase 2, Phase 3
size / enrollment: 38
Intervention Model: Parallel Assignment
Primary Purpose: Treatment
- FAP patient with previous colectomy and confirmed polyposis
- NSAID hypersensitivity
expertly curated content related to this topic
Primary and Secondary Restorative Proctocolectomy for Familial Adenomatous Polyposis: Complications and Long-Term Bo...AIM : The aim of the study was to evalua...
Pigmented and Depigmented Lesions of the Ocular FundusPURPOSE OF REVIEW: Pigmented and depigm...
A Phase Ib Study of the Effects of Black Raspberries on Rectal Polyps in Patients With Familial Adenomatous Polyposi...Familial adenomatous polyposis (FAP) is ...
Huntsman Cancer Institute study delves into reasons why preventive drug is effectiveA potent preventive treatment for people...
Hybrid Ameloblastoma and Adenomatoid Odontogenic Tumor: Report of a Case and Review of Hybrid Variations in the Lite...Hybrid odontogenic tumors including 2 or...
Risk of Colorectal Cancer For Carriers of Mutations in MutYH, With and Without a Family History of CancerWe studied 2332 individuals with monoall...
Ostomy Tips And TricksThere is a pretty steep learning curve f...